T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura (original) (raw)

Profile image of Stefan JacobssonStefan Jacobsson

2003, Nature Medicine

visibility

description

13 pages

link

1 file

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact

Pathobiology of Secondary Immune Thrombocytopenia

Howard Liebman

Seminars in Hematology, 2009

View PDFchevron_right

Thrombotic Thrombocytopenic Purpura: A Tale of Two Cases

Prakash Ghogale

2022

View PDFchevron_right

Immune thrombocytopenic purpura in two patients with Acute Lymphoblastic Leukemia

Vikramjit Kanwar

Pediatric Hematology Oncology Journal, 2018

View PDFchevron_right

Newly diagnosed versus relapsed idiopathic thrombotic thrombocytopenic purpura: a comparison of presenting clinical characteristics and response to treatment

Cristina Arbona

Annals of Hematology, 2009

View PDFchevron_right

Thrombotic thrombocytopenic purpura and other microangiopathies

Yulia Einav

The Obstetric Hematology Manual

View PDFchevron_right

Pathological Mechanisms and Novel Testing Methods in Thrombotic Thrombocytopenic Purpura

Robert W. Maitta

Biomedicines, 2024

View PDFchevron_right

Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study

Aristoteles Giagounidis

European Journal of Haematology, 2002

View PDFchevron_right

Persistent Immune Thrombocytopenia Resistant to Immunosuppressive Therapy: What Is the Way Forward?

Harini Vijayenthiran

Cureus, 2020

View PDFchevron_right

Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-Antibodies

Nora Goette

PLOS ONE, 2016

View PDFchevron_right

Thrombotic thrombocytopenic purpura presenting as recurrent thrombocytopenia in a young female — A case report

gayathri shanmugam

Hematology, Transfusion and Cell Therapy, 2019

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

Idiopathic thrombocytopenic purpura: Current concepts in pathophysiology and management

Maria Nica Evangelista

Thrombosis and Haemostasis, 2008

View PDFchevron_right

Interferon-alpha therapy in idiopathic thrombocytopenic purpura

Ömer DOĞRU

Pediatrics International, 2001

View PDFchevron_right

Immune Thrombocytopenic Purpura in Review

Nashwa Alzahrani

2021

View PDFchevron_right

IMMUNE THROMBOCYTOPENIC PURPURA: A HAEMATOLOGICAL DISORDER Review Article

International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS)

International Journal of Pharmacy and Pharmaceutical Sciences, 2024

View PDFchevron_right

Severe Ischemic Stroke in a Patients with Idiopathic Thrombocytopenic Purpura: A Case Report

Haluk gümüş

Türkiye Fiziksel Tip ve Rehabilitasyon Dergisi, 2015

View PDFchevron_right

Efficacy of different plasma sources in the treatment of thrombotic thrombocytopenic purpura

Arturo Pereira

ISBT Science Series, 2009

View PDFchevron_right

Management of Immune Thrombocytopenic Purpura in Adults

Jitendra Pariyar

Mayo Clinic Proceedings, 2004

View PDFchevron_right

Case report of rituximab-induced thrombocytopenia

sara grethlein

American Journal of Hematology, 2004

View PDFchevron_right

Recent Advances in the Treatment of Chronic Refractory Immune Thrombocytopenic Purpura

Kiarash Kojouri

International Journal of Hematology, 2005

View PDFchevron_right

Thrombotic thrombocytopenic purpura and systemic lupus erythematosus

David Fox

Annals of the Rheumatic Diseases, 1986

View PDFchevron_right

Tγ Cell Deficiency in Idiopathic Thrombocytopenic Purpura (ITP)

Marco Gobbi

Scandinavian Journal of Haematology, 1981

View PDFchevron_right

Purtscher's retinopathy as the presenting manifestation of immune thrombocytopenic purpura

Dean Eliott

American Journal of Ophthalmology Case Reports, 2017

View PDFchevron_right

Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance

Penny Ballem

Journal of Clinical Investigation, 1987

View PDFchevron_right

Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study

Sol Mercedes Lugo Sanchez

Hematology, 2017

View PDFchevron_right

The pathogenesis of immune thrombocytopaenic purpura

james bussel

British Journal of Haematology, 2006

View PDFchevron_right

Evaluation of 143 Cases of Immune Thrombocytopenic Purpura With Regards to Clinical Course and Response to Treatment

Zeynep Aki

The Eurasian Journal of Medicine, 2010

View PDFchevron_right

Response to B-cell–depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura

Maria Nica Evangelista

Blood, 2007

View PDFchevron_right

Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms

Anca Haisan

Medicina

View PDFchevron_right

Platelet transfusion in thrombotic thrombocytopenic purpura: between Scylla and Charybdis

Arturo Pereira

Transfusion, 2005

View PDFchevron_right

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers

Silvia D'angelo

Haematologica

View PDFchevron_right

Platelet activation and its patient-specific consequences

Waldemar Wysokinski

2008

View PDFchevron_right

Platelet activation in patients with thrombotic thrombocytopenic purpura

Maureane Hoffman

American Journal of Hematology, 1993

View PDFchevron_right

MedicinePerforinCase Control StudiesInterferon gammaIdiopathic thrombocytopenic purpuraBlood plateletsMedical and Health Sciences